Nutrition drink and gut health study for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests how an oral nutritional supplement affects the gut microbiome in people with type 2 diabetes. It uses a special capsule (SIMBA) to collect samples, and researchers want to see if the supplement leads to changes in your gut bacteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 65 years old
- You have type 2 diabetes, managed with up to 3 oral diabetes medicines (one must be metformin)
- Your most recent blood sugar test (HbA1c) is between 6.5% and 9.5%
- Your body mass index (BMI) is between 20 and 29.9
- Your weight has stayed within about 6.5 pounds (3 kg) for the last 2 months
- You are willing to swallow a large capsule (about 1 inch long) and follow the study routine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the SIMBA capsule to learn how gut bacteria (dysbiosis) relate to digestive conditions. It may help researchers better understand these conditions and how the capsule can be used safely.
This trial tests whether a personalized nutrition plan based on your gut bacteria (microbiome) can help improve blood sugar control in type 2 diabetes. Researchers will use artificial intelligence to match you with a diet tailored to your unique gut bacteria.
This study looks at how exercise affects gut bacteria in people with type 2 diabetes. It may help explain why physical activity improves diabetes control.
This trial tests if specific nutritional drinks can help people with type 2 diabetes spend more time with their blood sugar in a healthy range. It uses continuous glucose monitors to track results.
This study looks at how differences in gut microbes may relate to risk of developing type 2 diabetes. It may help researchers understand who is more likely to develop diabetes, and why.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.